Theragenics facing possible delisting - Atlanta Business Chronicle:

burdukovahycel.blogspot.com
million, and it now faces a possible delisting from the New YorkStockk Exchange. The Buford, Ga.-based surgical products and canced treatments company reported in Februaryhthat $63 million in goodwill impairment charge s . In a Securities and Exchangee filingon Monday, Theragenics (NYSE: TGX) said it got a lettet from NYSE saying it no longeer meets one of the continued listing standard. A listed companyt must maintain shareholders' equity of at least $75 millio if the company's average market capitalizationm has beenbelow $75 milliobn for over the last 30 tradingh days. The impairment charges and net loss for 2008 reducedthe company's stockholders' equity to $74.
1q million and Theragenics’ average global market capitalization for the past 30 tradinvg days has been below $75 million. Theragenics has 45 days from the lettet to submit a plan to NYSE that showzs it can get into compliance with the continue listing standards within the next18